bac·te·re·mi·a

(băk′tə-rē′mē-ə)

The presence of bacteria in the blood.

bac′te·re′mic (-mĭk) adj.

bac′te·re′mi·cal·ly adv.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bac•te•re•mi•a

(ˌbæk təˈri mi ə)

n.

the presence of bacteria in the blood.

[1885–90]

bac`te•re′mic (-mɪk) adj.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

bacteremia - transient presence of bacteria (or other microorganisms) in the blood

bacteriaemia, bacteriemia

microorganism, micro-organism - any organism of microscopic size

pathology - any deviation from a healthy or normal condition

Translations

βακτηριαιμία

bacteremia

n bacteriemia

Mentioned in

References in periodicals archive

MONDAY, July 8, 2019 (HealthDay News) -- The prevalence of infective endocarditis (IE) is about 26 percent among patients with Enterococcus faecalis bacteremia, according to a study published in the July 16 issue of the Journal of the American College of Cardiology.

Infective Endocarditis Prevalence 26 Percent in Patients With E. faecalis; Risk factors include prosthetic heart valve, community acquisition, monomicrobial bacteremia

cereus causes severe nongastrointestinal infections, such as bacteremia (2), endocarditis (3), meningoencephalitis (4), and pneumonia (5).

Novel Sequence Type in Bacillus cereus Strains Associated with Nosocomial Infections and Bacteremia, Japan

ContraFect announced that new data from its Phase 2 clinical trial of exebacase for the treatment of Staphylococcus aureus bacteremia including endocarditis was presented by Vance Fowler, M.D., Professor of Medicine in the Division of Infectious Diseases, Duke University at a late-breaker session at the 29th European Congress of Clinical Microbiology and Infectious Diseases, or ECCMID.

ContraFect presents additional data from exebacase Phase 2 clinical trial

aureus bacteremia in a case with late prosthesis infection and atypical complaints.

Effectiveness of FDG PET/CT in Metastatic Infections

The prevalence of the complicated UTI including bacteremia increases with age.1,2 The prevalence is high among elders with diabetes.

Geriatric urinary tract infections: The value of laboratory parameters in estimating the need for bacteremia and Intensive Care Unit

Infants with bacteremia caused by group B streptococcus (GBS) who were treated with intravenous antimicrobial therapy for 8 days or less had similarly successful outcomes, compared with those treated longer, based on data from 775 infants.

GROUP B STREP BACTEREMIA: Short-course IV therapy controls infant infection

In-hospital TB-related mortality rate was 19% (4/21) among MTBC-bacteremia patients and 4.8% (6/124) in those with no bacteremia (p = 0.017) (Table 1).

Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center

Tigecycline is an alternative for MDR Acinetobacter baumannii and Klebsiella pneumoniae carbapenemase-producing bacteria (KPC), but it is not recommended for bacteremia because it does not achieve adequate serum concentration levels and is associated to an increased risk of death (4-5).

Ceftazidime/Avibactam for Refractory Bacteremia, Vertebral Diskitis/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC)

Therefore, our study aimed to investigate the association of bacteremia with in-hospital mortality and the risk factors for bacteremia in cirrhotic patients with UGIB to assist decision-making for preventing complications, such as pneumonia and other infections, and treatment strategies of antibiotics use in the emergency department (ED).

Bacteremia in cirrhotic patients with upper gastrointestinal bleeding

Subsequent bacteremia was defined as at least one A .

Subsequent Multidrug-Resistant Bacteremia Is a Risk Factor for Short-Term Mortality of Patients with Ventilator-Associated Pneumonia Caused by Acinetobacter baumannii in Intensive Care Unit: A Multicenter Experience

Despite colistin and tigecycline as the last resorts, the optimal therapeutic regimen of CRAB bacteremia has not been established, and the unavailability of new antibiotic pipeline in developing countries definitely restricts clinical therapeutic options and facilitates its dissemination.

Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study